Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Name: Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
License: Public Domain

SOLTI Breast Cancer Research Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

melanoma triple-negative-breast-cancer

msi-h colorectal cancer, melanoma, anal carcinoma, mesothelioma, triple negative breast cancer, lung adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181763
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.